What if healing from depression didn’t take months of daily medication, but could begin with a single, guided experience? For decades, antidepressants have been the standard solution for treating depression. They’re familiar, accessible, and often effective. But for millions of people, especially those with treatment-resistant depression, the results fall short. Leaving them searching for alternatives.
In psychedelic therapy, two substances are drawing significant attention: ketamine and psilocybin (the active compound in “magic” mushrooms), both of which are considered psychedelic drugs. Both show promise in treating mental health conditions such as depression, anxiety, and trauma. Yet, they differ fundamentally in their mechanisms, effects, therapeutic use, and accessibility. These substances are among the emerging treatment options for
In a Nutshell A microdose is roughly one tenth to one twentieth of a full dose, deliberately sub-perceptual. For magic truffles that usually means 0.5 to 1 gram, depending on sensitivity. The Fadiman protocol doses every third day, one day on and two off. That schedule exists to prevent tolerance building up. Truffles are legal in the
Psilocybin, the main psychoactive molecule in “magic mushrooms,” is drawing significant attention for its transformative effects on perception, mood, and cognition. As a member of the class of psychoactive drugs, psilocybin influences the brain at multiple levels—from specific receptor interactions to large-scale brain networks—and these changes may translate into lasting therapeutic benefits for mental health
In a NutshellPsychedelic therapy combines a guided psilocybin session with talk therapy and integration.Research at Johns Hopkins and MAPS targets PTSD, depression, and anxiety.The immediate experience lasts four to eight hours, depending on substance and setting.Reported psychological benefits can last weeks or months after a single session.Studies also show promise for addiction, including alcohol and
In recent years, the global mental health landscape has shifted significantly, with increased attention on holistic approaches to wellbeing. Among these, psychedelic retreats have emerged as a fascinating area of study. A new publication, conducted in cooperation with the Essence Institute and the University of East London, delves into the outcomes of a 3-day psilocybin
Page [tcb_pagination_current_page] of [tcb_pagination_total_pages]